2. Becker C, Jick SS, Meier CR. Risk of stroke in patients with idiopathic Parkinson disease. Parkinsonism Relat Disord. 2010 Jan;16(1):31-5.
4. de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006 Jun;5(6):525-35.
5. Elkind MS, Ramakrishnan P, Moon YP, Boden-Albala B, Liu KM, Spitalnik SL, et al. Infectious burden and risk of stroke: the northern Manhattan study. Arch Neurol. 2010 Jan;67(1):33-8.
6. Gorell JM, Johnson CC, Rybicki BA. Parkinson’s disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990. Neurology. 1994 Oct;44(10):1865-8.
7. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003 Feb;91(3A):7A-11A.
8. Ho D, Imai K, King G, Stuart EA. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Soft. 2011 May;42(8):1-28.
9. Ho DE, Imai K, King G, Stuart EA. Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Political Analysis. 2007 15(3):199-236.
10. Hoshi T, Kitagawa K, Yamagami H, Furukado S, Hougaku H, Hori M. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke. 2005 Apr;36(4):768-72.
12. Jenner P. Oxidative stress in Parkinson’s disease. Ann Neurol. 2003 Mar;53 Suppl 3:S26-38.
13. Kang SH, Choi EK, Han KD, Lee SR, Lim WH, Cha MJ, et al. Underweight is a risk factor for atrial fibrillation: A nationwide population-based study. Int J Cardiol. 2016 Jul;215:449-56.
14. Kim YS, Kim JG, Yi J, Choi JM, Chung CK, Choi UY, et al. Changes in the medical burden of pyogenic and tuberculous spondylitis between 2007 and 2016: A nationwide cohort study. J Clin Neurosci. 2020 Mar;73:89-93.
15. Korten A, Lodder J, Vreeling F, Boreas A, van Raak L, Kessels F. Stroke and idiopathic Parkinson’s disease: does a shortage of dopamine offer protection against stroke? Mov Disord. 2001 Jan;16(1):119-23.
16. Lee DH, Choi YJ, Han IB, Hong JB, Do Han K, Choi JM, et al. Association of ischemic stroke with ankylosing spondylitis: a nationwide longitudinal cohort study. Acta Neurochir (Wien). 2018 May;160(5):949-55.
17. Lim SY, Lang AE. The nonmotor symptoms of Parkinson’s disease--an overview. Mov Disord. 2010 25 Suppl 1:S123-30.
18. McDonald C, Newton JL, Burn DJ. Orthostatic hypotension and cognitive impairment in Parkinson’s disease: Causation or association? Mov Disord. 2016 Jul;31(7):937-46.
19. Park CJ, Choi YJ, Kim JG, Han IB, Do Han K, Choi JM, et al. Association of acute myocardial infarction with ankylosing spondylitis: a nationwide longitudinal cohort study. J Clin Neurosci. 2018 Oct;56:34-7.
20. Park CS, Choi EK, Han KD, Lee HJ, Rhee TM, Lee SR, et al. Association between adult height, myocardial infarction, heart failure, stroke and death: a Korean nationwide population-based study. Int J Epidemiol. 2018 Feb;47(1):289-98.
21. Rektor I, Goldemund D, Sheardová K, Rektorová I, Michálková Z, Dufek M. Vascular pathology in patients with idiopathic Parkinson’s disease. Parkinsonism Relat Disord. 2009 Jan;15(1):24-9.
22. Roos RA, Jongen JC, van der Velde EA. Clinical course of patients with idiopathic Parkinson’s disease. Mov Disord. 1996 May;11(3):236-42.
23. Scigliano G, Musicco M, Soliveri P, Piccolo I, Ronchetti G, Girotti F. Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study. Stroke. 2006 May;37(5):1184-8.
27. Struck LK, Rodnitzky RL, Dobson JK. Stroke and its modification in Parkinson’s disease. Stroke. 1990 Oct;21(10):1395-9.